Filed before 2025Filed 19 March 2020
Silverback Therapeutics, Inc. raised $31.8M
Silverback Therapeutics, Inc., a biotech company based in Seattle, WA, raised $31.8M in a new equity round, according to a filing dated 19 March 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 19 March 2020
- Round
- Equity round
- Amount sold
- $31.8M
- Offering size
- $78.7M
- Investors so far
- 16
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 82% of the 1,744 tracked raises with an amount filed in 2020, and than 62% of the 152 in biotech.
Silverback Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 6 Oct 2020 | New filing | $85M | Another raise |
| 19 Mar 2020 | New filing | $31.8M | This raise |
More with Nextech Crossover on the board
- Stipple Bio, Inc.$65.1M
- Circle Pharma, Inc.$92.4M
- Alterome Therapeutics, Inc.$63.8M
- Revolution Medicines, Inc.$100M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.